跳至主要内容
临床试验/NCT06532435
NCT06532435已完成不适用

A Clinical Study on the Effect of DHA & ARA Candy on the Cognitive Improvement in Preschool Children of 2-6 Years Old

Shandong Sibote Biotechnology Co., Ltd.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年6月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Change of scale of WISC-IV-Chinese asssessment in 2 weeks

研究概览

简要总结

The goal of this interventional study is to evaluate the effectiveness of DHA (docosahexaenoic acid) & ARA (arachidonic acid) Candy on the cognitive development of preschool children (2-6 years old). The main questions it aims to answer are:

- Does DHA & ARA Candy improve the cognitive ability in terms of Wechsler Intelligence Scale for Children 4th edition-Chinese version (WISC-IV-Chinese)?

Researchers will administer the WISC-IV-Chinese following the guidelines strictly and analyze the score to conclude whether the DHA & ARA is effective to improve the cognitive ability of preschool childchildren.

Participants will eat 1-2 candy (each contains 100mg DHA and 100mg ARA) daily for 4 consecutive weeks and take the WISC-IV-Chinese test for three times according to the protocol.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
2 Years 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Participants must be 2-6 years old
  • Healthy children of normal development, without gender restrictions, with a male to female ratio of more than 40%;
  • During the trial period, participants agree not to take any medications, supplements, or other nutritional products containing DHA and ARA;
  • Parents or legal guardians (at least one party) have signed an informed consent form, voluntarily participating in this study and complying with the study design;
  • Willing to not participate in other interventional nutritional studies during the trial period;
  • Capable of fully understanding the nature, purpose, benefits, and potential risks and side effects of this study.

排除标准

  • Allergic to dairy products;
  • Severely intolerant to milk dairy products;
  • Unable to provide written informed consent;
  • During the screening period, or within the past two weeks, has used antibiotics;
  • Currently taking therapeutic medications;
  • The volunteer has any of the following medical histories or has been nutritionally diagnosed with any of the following diseases: significant gastrointestinal dysfunction, liver, kidney, endocrine, blood, respiratory, or cardiovascular diseases, which may affect the assessment of the trial's effects;
  • Suffering from any gastrointestinal dysfunction or gastrointestinal disease. For example, but not limited to: Irritable Bowel Syndrome (IBS), enteritis, ulcerative colitis, celiac disease, irritable bowel syndrome;
  • Has a history of hospitalization within the past 3 months;
  • According to the researcher's judgment, currently frequently using medications that may affect gastrointestinal function or the immune system.

结局指标

主要结局

Change of scale of WISC-IV-Chinese asssessment in 2 weeks

时间窗: base day 0, week 2

Change of scale of WISC-IV-Chinese (Wechsler Intelligence Scale for Children 4th edition-Chinese version). The WISC-IV-Chinese is an individually administered and norm-referenced instrument designed to measure intelligence for Chinese children. The WISC-IV contains 10 core subtests and five additional subtests. These are summed into a four-index score and one FSIQ, which ranges from the lowest (40) to the highest (160) points.

Change of scale of WISC-IV-Chinese asssessment in 4 weeks

时间窗: base day 0, week 4

Change of scale of WISC-IV-Chinese (Wechsler Intelligence Scale for Children 4th edition-Chinese version). The WISC-IV-Chinese is an individually administered and norm-referenced instrument designed to measure intelligence for Chinese children. The WISC-IV contains 10 core subtests and five additional subtests. These are summed into a four-index score and one FSIQ, which ranges from the lowest (40) to the highest (160) points.

次要结局

  • Number of sick leave days(base day 0, week 2, week 4)
  • Change of Conners TRS score(base day 0, week 2, week 4)

研究者

发起方
Shandong Sibote Biotechnology Co., Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验